Aethir vs Enzyme — how do they compare? Aethir trades at Rp69.88 (market cap Rp1,41T, Rp94,28M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Aethir is far larger — about 10512.2× Enzyme's market cap, and Aethir's supply is capped (20,1B / 42B ATH (48%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Aethir for 39 Days and Enzyme for 29 Days on average.
| ATH | MLN | |
|---|---|---|
Market Cap | Rp1,41T | Rp134,13M |
Volume (24h) | Rp94,28M | Rp104,56M |
Circulating Supply | 20,1B / 42B ATH (48%) | 3,3M MLN |
Typical Hold Time | 39 Days | 29 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
Aethir is best described as distributed cloud compute infrastructure. It aggregates enterprise-grade GPU chips into a single global network to increase the supply of on-demand cloud compute resources for the AI, gaming, and virtualized compute sectors.
Read more on ATH →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →